P
PreDx develops bio-responsive MRI contrast agents designed to visualize cellular processes in real-time within living tissue. This technology provides non-invasive, dynamic insight into disease progression and therapeutic efficacy, such as monitoring senescent cell activity. The agents accelerate preclinical and clinical drug development by enabling continuous, quantitative assessment of treatment response.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- PreDx develops bio-responsive MRI contrast agents that provide real-time, non-invasive visualization of cellular processes within living tissue. This technology allows researchers to monitor dynamic events like senescent cell accumulation and gene therapy activation with high accuracy. The agents accelerate drug development and clinical trials by enabling continuous, quantitative assessment of treatment efficacy without requiring biopsies.